🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Compounded tirz stability at room temperature — what worked for you?

Compounded tirz stability at room temperature — what worked for you?

MikeFit_NJ Fri, Aug 30, 2024 at 5:56 AM 13 replies 1,843 viewsPage 1 of 3
This thread is more than 21 months old. Information may be outdated. Consider searching for more recent discussions.
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Aug 30, 2024 at 5:56 AM#1

I froze a spare vial thinking I was being careful and later found out that is the one thing you are not supposed to do.

Practical: unopened, refrigerated at 2 to 8°C; in use, refrigerated and used within the preservative-limited window; never frozen; and a visual check every time — a haze that does not settle is a reason to stop, not to wonder.

What I am after is what a temperature excursion actually does, and what distinguishes an unopened vial from one already in use.

Tell me what I have not thought of.

31 1LeilaHI, marcus_mpls, DeniseRN_TPA and 28 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Aug 30, 2024 at 6:41 AM#2

Taking the question as asked, rather than the general version of it. They are two different exemptions from the same federal requirements and they buy different things. A 503A pharmacy is regulated primarily by the state board, needs a patient-specific prescription, is exempt from CGMP, and may use a bulk substance that has a USP monograph, is a component of an approved drug, or appears on the 503A bulks list — three independent doorways. A 503B outsourcing facility registers with the FDA, is inspected on a risk basis, must comply with CGMP, may compound for office stock without a patient-specific prescription, and has one doorway to a permitted bulk substance: the 503B bulks list, or the drug shortage list.

30 0Admin, Dr.Martinez, mike_mod and 27 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Aug 30, 2024 at 7:26 AM#3
FDA_TrackerJim said:
They are two different exemptions from the same federal requirements and they buy different things.

FDA_TrackerJim has the substance of this right. The condition it depends on is worth stating. Freezing is the one to avoid, and freeze-thaw more so. Ice-crystal formation and the concentration changes at the phase boundary drive aggregation, and aggregated peptide does not recover on thawing. A vial that has been frozen and thawed is not rescued by returning it to the fridge.

29 24TomFromTexas, mike.trainer_LA, sarah_nash92 and 26 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Aug 30, 2024 at 8:11 AM#4
MikeFit_NJ said:
I froze a spare vial thinking I was being careful and later found out that is the one thing you are not supposed to do.

Agreed, and the enforcement dates were staggered by category — 503A first, 503B a few weeks later — because outsourcing facilities have manufactured inventory and clinic contracts to unwind while a 503A makes to order.

I would rather be corrected than agreed with, if it comes to it.

28 23FranDenver, Dr.BariatricHTX, LindaRN_retired and 25 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Aug 30, 2024 at 12:24 PM#5

From the other side of the consultation, briefly.

Storage best practices for compounded storage and cold:

  • Unreconstituted lyophilized powder: refrigerate (36-46°F), good for 12+ months
  • Reconstituted vials: refrigerate, use within 28 days
  • Pre-filled pens: refrigerate until first use, then room temp OK for 28 days
  • Never freeze reconstituted peptides — ice crystals damage the protein
  • Protect from light — store in original box or wrap in foil

When in doubt, refrigerate. Temperature abuse is the #1 cause of reduced potency in compounded peptides.

Last edited: Aug 30, 2024 at 4:24 PM
27 22ChrisMacros, KetoKyle, CanadaChris and 24 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register